172 related articles for article (PubMed ID: 31960603)
1. Anabolic and lipolytic actions of beta
Hostrup M; Jacobson GA; Jessen S; Lemminger AK
Drug Test Anal; 2020 May; 12(5):597-609. PubMed ID: 31960603
[TBL] [Abstract][Full Text] [Related]
2. Beta2-Agonist Doping Control and Optical Isomer Challenges.
Jacobson GA; Fawcett JP
Sports Med; 2016 Dec; 46(12):1787-1795. PubMed ID: 27164986
[TBL] [Abstract][Full Text] [Related]
3. The salmeterol anomaly and the need for a urine threshold.
Jacobson GA; Hostrup M
Drug Test Anal; 2022 Jun; 14(6):997-1003. PubMed ID: 32314556
[TBL] [Abstract][Full Text] [Related]
4. Terbutaline: level the playing field for inhaled β
Jacobson GA; Hostrup M
Br J Sports Med; 2017 Sep; 51(18):1323-1324. PubMed ID: 27461883
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of salmeterol and its main metabolite α-hydroxysalmeterol after acute and chronic dry powder inhalation in exercising endurance-trained men: Implications for doping control.
Jessen S; Becker V; Rzeppa S; Backer V; Bengtsen KH; Hullstein I; Dehnes Y; Hostrup M
Drug Test Anal; 2021 Apr; 13(4):747-761. PubMed ID: 33210444
[TBL] [Abstract][Full Text] [Related]
6. Ergogenic effects of inhaled beta2-agonists in non-asthmatic athletes.
Wolfarth B; Wuestenfeld JC; Kindermann W
Endocrinol Metab Clin North Am; 2010 Mar; 39(1):75-87, ix. PubMed ID: 20122451
[TBL] [Abstract][Full Text] [Related]
7. Can β2-agonists have an ergogenic effect on strength, sprint or power performance? Systematic review and meta-analysis of RCTs.
Riiser A; Stensrud T; Stang J; Andersen LB
Br J Sports Med; 2020 Nov; 54(22):1351-1359. PubMed ID: 32747344
[TBL] [Abstract][Full Text] [Related]
8. Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes?
Kindermann W
Sports Med; 2007; 37(2):95-102. PubMed ID: 17241101
[TBL] [Abstract][Full Text] [Related]
9. Sports doping: emerging designer and therapeutic β2-agonists.
Fragkaki AG; Georgakopoulos C; Sterk S; Nielen MW
Clin Chim Acta; 2013 Oct; 425():242-58. PubMed ID: 23954776
[TBL] [Abstract][Full Text] [Related]
10. Formoterol concentrations in blood and urine: the World Anti-Doping Agency 2012 regulations.
Eibye K; Elers J; Pedersen L; Henninge J; Hemmersbach P; Dalhoff K; Backer V
Med Sci Sports Exerc; 2013 Jan; 45(1):16-22. PubMed ID: 22843108
[TBL] [Abstract][Full Text] [Related]
11. Inhaled beta2 agonists and performance in competitive athletes.
Kindermann W; Meyer T
Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i43-7. PubMed ID: 16799103
[TBL] [Abstract][Full Text] [Related]
12. Enantioselective disposition of (R)-salmeterol and (S)-salmeterol in urine following inhaled dosing and application to doping control.
Jacobson GA; Hostrup M; Narkowicz CK; Nichols DS; Haydn Walters E
Drug Test Anal; 2017 Aug; 9(8):1262-1266. PubMed ID: 28033454
[TBL] [Abstract][Full Text] [Related]
13. Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes.
Carlsen KH; Hem E; Stensrud T; Held T; Herland K; Mowinckel P
Respir Med; 2001 Jul; 95(7):571-6. PubMed ID: 11453313
[TBL] [Abstract][Full Text] [Related]
14. Beta
Hostrup M; Narkowicz CK; Habib S; Nichols DS; Jacobson GA
Drug Test Anal; 2019 Jul; 11(7):1048-1056. PubMed ID: 30836453
[TBL] [Abstract][Full Text] [Related]
15. Combined inhalation of beta2 -agonists improves swim ergometer sprint performance but not high-intensity swim performance.
Kalsen A; Hostrup M; Bangsbo J; Backer V
Scand J Med Sci Sports; 2014 Oct; 24(5):814-22. PubMed ID: 23834392
[TBL] [Abstract][Full Text] [Related]
16. Review of WADA Prohibited Substances: Limited Evidence for Performance-Enhancing Effects.
Heuberger JAAC; Cohen AF
Sports Med; 2019 Apr; 49(4):525-539. PubMed ID: 30411235
[TBL] [Abstract][Full Text] [Related]
17. A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease.
Sovani MP; Whale CI; Tattersfield AE
Drug Saf; 2004; 27(10):689-715. PubMed ID: 15350154
[TBL] [Abstract][Full Text] [Related]
18. β
Hudzik TJ; Patel M; Brown A
Drug Test Anal; 2021 Feb; 13(2):261-267. PubMed ID: 33369180
[TBL] [Abstract][Full Text] [Related]
19. Beyond bronchodilation: Illuminating the performance benefits of inhaled beta
Hostrup M; Jessen S
Scand J Med Sci Sports; 2024 Jan; 34(1):e14567. PubMed ID: 38268072
[TBL] [Abstract][Full Text] [Related]
20. High-dose inhaled salbutamol has no acute effects on aerobic capacity or oxygen uptake kinetics in healthy trained men.
Elers J; Mørkeberg J; Jansen T; Belhage B; Backer V
Scand J Med Sci Sports; 2012 Apr; 22(2):232-9. PubMed ID: 21083771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
